Oscar Health Inc

For the period ended Jun 30, 2024. Filed Aug 7, 2024.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2024 · Filed Aug 7, 2024

OSCR$33.47+4.1%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Condensed Consolidated Statements of Stockholders' Equity

Class A · Class B
(in thousands)	Shares	Amount	Shares	Amount	Treasury Stock	Additional Paid-In Capital	Accumulated Deficit	Accumulated Other Comprehensive Income (Loss)	Noncontrolling Interests	Total Stockholders' Equity
December 31, 2023	193,875	$2	35,514	$—	$(2,923)	$3,682,294	$(2,876,715)	$1,309	$2,150	$806,117
Issuance of common stock from equity incentive plans	6,622	—	—	—	—	27,309	—	—	—	27,309
Stock-based compensation expense	—	—	—	—	—	27,282	—	—	—	27,282
Unrealized losses on investments, net	—	—	—	—	—	—	—	(3,903)	—	(3,903)
Net income	—	—	—	—	—	—	177,368	—	114	177,482
March 31, 2024	200,497	$2	35,514	$—	$(2,923)	$3,736,885	$(2,699,347)	$(2,594)	$2,264	$1,034,287
Issuance of common stock from equity incentive plans	5,656	—	—	—	—	18,702	—	—	—	18,702
Stock-based compensation expense	—	—	—	—	—	31,298	—	—	—	31,298
Unrealized losses on investments, net	—	—	—	—	—	—	—	(31)	—	(31)
Net income	—	—	—	—	—	—	56,207	—	105	56,312
June 30, 2024	206,153	$2	35,514	$—	$(2,923)	$3,786,885	$(2,643,140)	$(2,625)	$2,369	$1,140,568

Condensed Consolidated Statements of Stockholders' Equity Cont.

Class A · Class B
(in thousands)	Shares	Amount	Shares	Amount	Treasury Stock	Additional Paid-In Capital	Accumulated Deficit	Accumulated Other Comprehensive Income (Loss)	Noncontrolling Interests	Total Stockholders' Equity
December 31, 2022	181,176	$2	35,116	$—	$(2,923)	$3,509,007	$(2,605,987)	$(9,715)	$2,016	$892,400
Issuance of common stock from equity incentive plans	2,057	—	—	—	—	35	—	—	—	35
Stock-based compensation expense	—	—	—	—	—	73,248	—	—	—	73,248
Joint venture contributions	—	—	—	—	—	471	—	—	—	471
Unrealized gains on investments, net	—	—	—	—	—	—	—	5,236	—	5,236
Net loss	—	—	—	—	—	—	(39,772)	—	144	(39,628)
March 31, 2023	$183,234	$2	$35,116	$—	$(2,923)	$3,582,761	$(2,645,759)	$(4,479)	$2,160	$931,762
Issuance of common stock from equity incentive plans	3,556	—	—	—	—	2,551	—	—	—	2,551
Stock-based compensation expense	—	—	—	—	—	35,454	—	—	—	35,454
Unrealized losses on investments, net	—	—	—	—	—	—	—	(2,377)	—	(2,377)
Net loss	—	—	—	—	—	—	(15,528)	—	103	(15,425)
June 30, 2023	186,790	$2	35,116	$—	$(2,923)	$3,620,766	$(2,661,287)	$(6,856)	$2,263	$951,965

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.